Glucagon-like peptide-1 receptor agonists reduce experimental atherosclerosis progression, inflammatory biomarkers and cardiovascular events, irrespective of hyperglycaemia and obesity

Journal:

European Heart Journal

Published:

2026-04-02

DOI:

10.1093/eurheartj/ehag060

Affiliations:

8

Authors:

19

Go to article

Institutions	Authors	Share
Massachusetts General Hospital (MGH), United States of America (USA)	14.666667 14.666667	0.77
Brigham and Women's Hospital (BWH), United States of America (USA)	2.000000	0.11
Mount Sinai Heart, United States of America (USA)	1.000000	0.05
Case Western Reserve University (CWRU), United States of America (USA)	0.500000	0.03
Addenbrooke's Hospital, United Kingdom (UK)	0.500000	0.03
Harvard-MIT Health Sciences and Technology (HST), United States of America (USA)	0.333333	0.02

Interested in Pharmacology and Pharmaceutical Sciences?